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Insulin-Like Growth Factor-1 Induces Lipid
Production in Human SEB-1 Sebocytes Via
Sterol Response Element-Binding Protein-1
Terry M. Smith1,3, Zhaoyuan Cong1,2, Kathryn L. Gilliland1,2, Gary A. Clawson1,3,4 and Diane M. Thiboutot1,2
An understanding of the molecular signaling involved in sebaceous gland lipid production is needed to develop
therapeutic targets to improve acne. Treatment with methylisobutylxanthine, dexamethasone, and a high dose
of insulin (MDI) has been shown to differentiate 3T3-L1 preadipocytes into adipocytes, a differentiation marked
by an increase in lipid production. The present study has the following aims: (1) Since high doses of insulin, as
found in MDI, will activate the IGF-1 receptor, we sought to determine if IGF-1 is capable of reproducing the
lipogenic effect seen with MDI treatment, and (2) to determine if the sterol response element-binding protein-1
(SREBP-1) pathway mediates the increase in lipogenesis. Here we report that MDI increases lipogenesis and that
this effect can be attributed wholly to the high-dose insulin in SEB-1 cells. Further, we show that a
physiologically relevant dose of IGF-1 or high-dose (1 mM) insulin induces an increase in SREBP-1 mRNA, protein,
and total lipid production; while 100 nM insulin induces lipogenesis yet the SREBP protein levels remain
unchanged. These data indicate that activation of the IGF-1 receptor increases lipogenesis in SEB-1 cells through
both SREBP-dependent and SREBP-independent pathways.
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INTRODUCTION
Sebum production is pivotal in the pathogenesis of acne. An
understanding of the factors that regulate this process is
important in designing strategies to improve acne. The peak
incidence of acne occurs during adolescence when serum
IGF-1 levels reach their peak during the growth spurt
(Deplewski and Rosenfield, 1999), and IGF-1 levels correlate
positively with severity of acne in women with clinical acne
(Cappel et al., 2005). The IGF-1 receptor is expressed on
sebocytes and can be activated by either IGF-1 or high doses
of insulin (Rudman et al., 1997).
Insulin, in combination with the hormones methylisobutyl-
xanthine and dexamethasone, is commonly used to induce the
differentiation of 3T3-L1 preadipocytes into adipocytes, a process
which is characterized by a marked increase in lipogenesis
(Student et al., 1980). A role for IGF-1 and insulin in stimulating
sebaceous gland lipogenesis was first demonstrated in rat
preputial sebocytes (Deplewski and Rosenfield, 1999).
The sterol response element-binding proteins (SREBPs) are
nuclear transcription factors that regulate the synthesis of
cholesterol and fatty acids. As suggested by their name,
SREBPs bind sterol response elements in the promoters of
genes involved in lipogenesis, including fatty acid synthase,
long-chain fatty acyl elongase, stearoyl CoA desaturase,
HMG CoA synthase, HMG CoA reductase, and squalene
synthase (Horton, 2002). SREBPs are produced as precursors
embedded in the endoplasmic reticulum. In sterol-depleted
cells, two sequential cleavages release the amino terminal
fragment of the protein, which in turn enters the nucleus and
binds to promoters of genes containing sterol response
elements, activating transcription (Hua et al., 1996; Sakai
et al., 1996). There are three known SREBPs that regulate
synthesis of cholesterol and fatty acids. SREBP-1a and 1c are
derived from a single gene with alternate start sites, yielding a
different first exon (Shimomura et al., 1997). SREBP-2 is the
third member of the family and is believed to be more active
in cholesterol homeostasis, though there is some functional
overlap between the two forms (Sakai et al., 1996).
The goal of this study was to examine the mechanism(s) by
which adipogenic hormones increase lipogenesis in human
SEB-1 sebocytes and to test the hypothesis that SREBPs are
key regulators of this process. Here we report that: (1) the
increased lipogenesis observed in SEB-1 cells treated with
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methylisobutylxanthine, dexamethasone, and a high dose of
insulin (MDI) is attributed to insulin; (2) physiologically
relevant doses of IGF-1 increase lipogenesis in SEB-1
sebocytes; and (3) increased expression of SREBP-1 mRNA
and protein mediates the increase in lipid production by IGF-1
and augments the increase by 1 mM insulin. Additionally,
100 nM insulin increases lipogenesis to a statistically lesser
extent than 1 mM insulin or 20 ng/ml IGF-1 in SEB-1 sebocytes.
From this we conclude that insulin and IGF-1 can potentially
activate lipogenesis by different mechanisms. These data also
suggest that the IGF-1 receptor is instrumental in activating
the SREBP pathway and the downstream increases in
lipogenesis in SEB-1 cells.
RESULTS
Insulin is the component in MDI media that increases
lipogenesis in SEB-1 cells
Statistically significant increases in the incorporation of 14C
acetate into sebaceous lipids were noted when SEB-1 cells
were treated with methylisobutylxanthine (0.5 mM), dexa-
methasone (0.3 mM), and insulin (1.74 mM) together with 10%
fetal bovine serum (Figure 1a). Specifically, cholesterol was
increased 4.4-fold, fatty alcohol was increased 3.6-fold,
triglycerides were increased 4.8-fold, cholesterol oleate was
increased 9.5-fold, and squalene was increased 14.2-fold.
However, when SEB-1 cells were treated with each of the
three hormones individually in 10% fetal bovine serum, only
insulin significantly increased lipogenesis (Figure 1b). There
were no significant changes in lipogenesis when cells were
treated with either methylisobutylxanthine or dexamethasone
alone (data not shown).
Lipogenesis is increased by 100 nM insulin, 1 lM insulin, and
IGF-1 in SEB-1 sebocytes
Because insulin at high concentrations is capable of acting
through the IGF-1 receptor (Prisco et al., 1999), we tested
whether a physiologically relevant dose of IGF-1 (20 ng/ml)
could mimic the lipogenic effect observed with 1.74 mM
insulin. We also wanted to determine if a lower dose of
insulin would cause the same increase in lipogenesis as the
high dose of insulin which was likely acting through both the
IGF-1 and insulin receptor.
Statistically significant increases in the production of
cholesterol, cholesterol oleate, fatty alcohol, and triglycerides
were noted when SEB-1 cells were treated with 100 nM
insulin (Figure 2). Treatment with either IGF-1 or 1 mM insulin
significantly increased all eight lipid species when compared
to the vehicle control (Figure 2). Further, the increases
induced by 1 mM insulin were significantly greater than those
induced by 100 nM insulin in all eight lipids; and significantly
greater incorporation of acetate into cholesterol, oleic acid,
triglycerides, and wax esters was achieved with IGF-1
compared to 100 nM insulin (Figure 2).
SREBP-1 protein is induced in SEB-1 cells by IGF-1 and 1 lM
insulin but not by 100 nM insulin
Since SREBPs regulate numerous genes involved in lipid
metabolism, we tested whether the effects of IGF-1 on
lipogenesis were mediated by SREBPs. Western blot demon-
strated that both the precursor and mature forms of the
SREBP-1 protein are increased by 6- and 3-fold, respectively,
in response to IGF-1 (Figure 3a and b). Additionally, the
precursor is increased by 2.7-fold and the mature protein is
increased by 1.7-fold in response to 1 mM insulin, a dose
known to activate the IGF receptor. Interestingly, although
the lower dose of insulin (100 nM) increased lipogenesis, it
did not increase SREBP protein expression (Figure 3c and d).
These results suggest that the moderate increase in lipogen-
esis in SEB-1 cells induced by 100 nM insulin does not involve
upregulation of SREBP-1, while the greater increase seen with
1 mM insulin or 20 ng/ml IGF-1 are at least, in part, mediated
by the SREBP-1 pathway.
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Figure 1. Treatment of SEB-1 sebocytes with adipogenic hormones increases
14C acetate incorporation into non-polar lipids. This increase can be
attributed to insulin. (a) SEB-1 sebocytes were treated with methylisobutyl-
xanthine (0.5 mM), dexamethasone (0.3 mM), and insulin (1.74 mM) for 72 hours.
Cells were then incubated with 14C acetate for 2 hours. Lipids were extracted
and separated by thin layer chromatography. (b) Insulin alone increases
lipogenesis in SEB-1 sebocytes. Treatment with methylisobutylxanthine or
dexamethasone alone did not change lipogenesis (not shown). Units are
expressed as mean7SE c.p.m./hour/104 cells. Significance was determined
by t-test and a P-value ofo0.05 in comparison to the vehicle was determined
to be significant and denoted with an *. The following abbreviations are used:
C¼ cholesterol; FOH¼ fatty alcohol; OA¼ oleic acid; TAG¼ triglycerides;
CO¼ cholesterol oleate; SQ¼ squalene.
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Both the SREBP-1a and 1c mRNA transcripts are increased in
SEB-1 cells treated with IGF-1 and insulin
Quantitative reverse-transcription PCR (QPCR) was per-
formed to determine if the SREBP-1a or 1c transcripts were
increased in response to IGF-1 or insulin treatment. Treat-
ment of SEB-1 sebocytes with 20 ng/ml IGF-1 produced a
statistically significant increase in mRNA for both SREBP-1a
(3.3-fold increase) and SREBP-1c (4.7-fold increase) (Figure
4a). Treatment with either 100 nM insulin or 1mM insulin also
increased SREBP-1a and 1c mRNA (Figure 4b). The increase
in response to 100 nM insulin was surprising, as no changes in
SREBP-1 protein were noted at this dose (Figure 3d). The
increase in both SREBP-1a and 1c transcripts in response to
100 nM insulin, combined with the lack of increase in SREBP-1
protein at this dose, implies another level of regulation,
perhaps post-transcriptional, that has not been observed for
SREBP-1.
The ratios of SREBP-1c:SREBP-1a differ between human
sebaceous glands and SEB-1 sebocytes
Several reports have indicated that the SREBP-1c:1a ratio
is markedly different in cell lines compared to tissue
(Shimomura et al., 1997). It is typical for the SREBP-1c
form to predominate in tissue, while immortalized cell lines
have much more SREBP-1a than 1c. We performed QPCR
to compare the respective SREBP-1c:1a ratios and found this
to be true for SEB-1 cells as well. Sebaceous glands had a
1c:1a ratio of 9.8:1, whereas, the SEB-1 cell line had a
SREBP-1c:1a ratio of 0.59:1 (Figure 5).
The ratio of insulin receptor isoform A:isoform B is 5.1:1 in SEB-1
sebocytes
The isoform of insulin receptor present in cells can have a
profound impact on the insulin signaling. There have been
two isoforms of the insulin receptor described, isoform A
lacks exon 11, while isoform B retains exon 11. We
performed QPCR to determine which isoform was prevalent
in the SEB-1 sebocytes. We found that the isoform A (exon
11) was more prevalent than isoform B (exon 11þ ) by a
ratio of 5.1:1 (Figure 6).
DISCUSSION
Acne is the most common skin condition observed by
clinicians, and at times it has been considered ‘‘physiologic’’
in the adolescent population (Kligman, 1974). Sebum
production by the sebaceous gland is fundamental in the
pathophysiology of acne and, apart from isotretinoin or
hormonal therapy, there are no effective means to reduce
sebum production. An understanding of the factors that
regulate sebum production is crucial to making advances in
acne therapy (Harper and Thiboutot, 2003).
While sebocytes are epithelial cells and adipocytes are
mesenchymal cells, similarities exist in that each of these cell
types make lipid as part of their process of differentiation, as
first noted by Rosenfield et al. (1999). The adipogenic
hormones methylisobutylxanthine, dexamethasone, and
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Figure 2. Treatment of SEB-1 sebocytes with 100 nM insulin increases
lipogenesis, though to a lesser extent than 1 lM insulin or 20 ng/ml IGF-1.
SEB-1 sebocytes were treated for 24 hours with 100 nM insulin, 1 mM insulin, or
20 ng/ml IGF-1. Cells were then incubated with 14C acetate for 2 hours. Lipids
were extracted and separated by thin layer chromatography. Units are
expressed as mean7SE c.p.m./hour/104 cells. Analysis of variance was used
to determine statistical significance. Date by treatment interaction was
observed for some data points. A P-value of o0.05 in comparison to the
vehicle was determined to be significant and denoted with an *, while a
P-value of o0.05 compared to 100 nM insulin is denoted by an z. The
following abbreviations are used: C¼ cholesterol; FOH¼ fatty alcohol;
OA¼oleic acid; TAG¼ triglycerides; CO¼ cholesterol oleate; SQ¼ squa-
lene; WE=wax esters.
Precursor
80 kDa
Mature
Actin
0 20 ng/ml
Precursor
80 kDa
Mature
Actin
0
100 
nM 1 M
Precursor Mature
SREBP
0
0.5
1
1.5
2
2.5
3
3.5
R
el
at
iv
e 
am
ou
nt
 o
f
SR
EB
P 
pr
ot
ei
n
Control
100 nM Insulin
1 M Insulin
*
*
d
0
1
2
3
4
5
6
7
8
9
Precursor Mature
SREBP
R
el
at
iv
e 
am
ou
nt
 o
f
SR
EB
P 
pr
ot
ei
n Control20 ng/ml IGF-1
*
*
b
c
a
Figure 3. Both forms of the SREBP-1 protein are increased in SEB-1
sebocytes treated with 20 ng/ml IGF-1 or 1 lM insulin, but not with 100 nM
insulin. SEB-1 sebocytes were treated 24 hours with insulin or IGF-1. Protein
was isolated and a Western blot was performed, probing with antibodies to
SREBP-1 and actin. (a) is a representative blot probed for SREBP-1 following
20 ng/ml IGF-1 treatment. (b) These data were normalized to actin and
quantified. (c) Representative blot probed for SREBP-1 and normalized to
actin following insulin treatment: 100 nM (lane 2) and 1 mM (lane 3). (d) These
data are quantified. (b and d) All blots were repeated a minimum of five times,
analyzed by densitometry and normalized to actin. Densitometer data were
compared to vehicle-treated blots and Student’s t-test was performed.
A P-value o0.05 was determined to be statistically significant.
1228 Journal of Investigative Dermatology (2006), Volume 126
TM Smith et al.
IGF-1 Induces Lipogenesis in SEB-1 Cells Via SREBP-1
insulin induce the differentiation of preadipocytes into
adipocytes which is accompanied by a change in morphol-
ogy, increased expression of the peroxisome proliferator-
activated receptor gamma, and the accumulation of intracel-
lular lipid (Rosen et al., 2000). In this paper, we show that
adipogenic hormones increase lipid production in SEB-1
sebocytes, similar to their actions in adipocytes, and that this
effect can be induced by insulin. Additionally, this effect can
be reproduced by IGF-1.
Both insulin and IGF-1 are members of the receptor
tyrosine kinase subfamily. It is crucial to note that although
each molecule has its own receptor, insulin can bind to the
IGF-1 receptor with an affinity 100-fold less than to its native
receptor. Likewise, IGF-1 will bind to the insulin receptor
with 100–1,000 times less affinity than it has for its own
receptor (Jones and Clemmons, 1995). This matter is further
complicated by alternative splicing that has been observed
for the insulin receptor, which alters both the signaling and
affinity for insulin, IGF-1, and IGF-II (Denley et al., 2003). As
1 mM insulin can activate the IGF-1 receptor in addition to the
insulin receptor (Prisco et al., 1999), we also treated the SEB-1
cells with a lower dose of insulin (100 nM) or with IGF-1
(20 ng/ml). The lower dose of insulin was able to induce
lipogenesis to a moderate extent, but the IGF-induced
lipogenesis to a significantly greater extent than 100 nM
insulin, and to approximately the same levels as 1 mM insulin
(Figure 2). From this we conclude that IGF-1 receptor
activation is a key driver of lipogenesis in SEB-1 sebocytes.
This hypothesis is supported by the fact that 3T3-L1
preadipocytes can be differentiated by IGF-1 or 2 mM insulin,
from which it was deduced that IGF-1 is the essential
regulator of differentiation in the 3T3-L1 line (Smith et al.,
1988).
Our data support those of Deplewski and Rosenfield
(1999) who found increased lipid content in rat preputial
cells following treatment with insulin and IGF-1. IGF-1 at
1 nM (7.7 ng/ml) stimulates differentiation to the same degree
as 1 mM insulin in the rat preputial sebocyte model. In another
study, isolated human sebaceous glands from chest skin
that were grown in the presence of 50 ng/ml IGF-1 for 3 days
showed an increase in 14C acetate incorporation into non-
polar lipids that was comparable to that achieved by 1.8mM
insulin (Downie et al., 2002, 2004). Our data demonstrate
that IGF-1 at a dose of 20 ng/ml increases lipogenesis to the
same extent as insulin at 1 mM. Taken together, these
data indicate that the lipogenic enzymes in sebaceous glands
and sebocytes are maximally stimulated by physiologically
relevant doses of IGF-1 as evidenced by the increase in
acetate incorporation into lipids. Under the experimental
conditions used in this study (serum-free medium),
an increase in the mass of lipids was not noted (data not
shown).
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Figure 4. Both SREBP-1a and SREBP-1c mRNA transcripts are increased in
SEB-1 sebocytes treated with 20 ng/ml IGF-1, 100 nM insulin, or 1 lM insulin.
SEB-1 sebocytes were treated with (a) IGF-1 or (b) insulin for 14 hours.
Following treatment, RNA was isolated and subjected to QPCR to determine
abundance of the SREBP-1a and SREBP-1c transcript in comparison to
vehicle-treated cells. Data were analyzed using the relative expression
software tool program and Student’s t-test was performed. A P-value o0.05
was considered statistically significant. Using the relative expression software
tool program, it is not possible to generate SD or SE unless the same RT
reaction is run repeatedly, thus P-values are used to gauge variation.
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Figure 5. The ratio of SREBP-1c:1a mRNA in SEB-1 sebocytes is 0.59:1,
while the ratio is 9.8:1 in sebaceous gland. Human sebaceous glands were
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QPCR to determine the relative ratio of SREBP-1c:1a. RNA was also extracted
from SEB-1 cells to determine the SREBP-1c:1a ratio by QPCR. Data represent
the mean ratios of five determinations7SE.
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Figure 6. The ratio of insulin receptor isoform A:isoform B mRNA is 5.1:1 in
SEB-1 sebocytes. RNA was extracted from SEB-1 sebocytes and QPCR was
performed to determine the ratio of insulin receptor isoform A to insulin
receptor isoform B. Data represent the mean ratios of five determinations7SE.
www.jidonline.org 1229
TM Smith et al.
IGF-1 Induces Lipogenesis in SEB-1 Cells Via SREBP-1
A possible mechanism for this increase in rate of
lipogenesis in response to insulin and IGF-1 treatment
involves the SREBP pathway. The SREBPs are key transcrip-
tional regulators of lipogenic enzymes (Horton, 2002). Their
expression is upregulated in response to insulin in tissues
such as liver, fat, and skeletal muscle (Kim et al., 1998; Foretz
et al., 1999; Guillet-Deniau et al., 2002). We hypothesized
that the effects of insulin and IGF-1 on lipogenesis in SEB-1
sebocytes may be mediated via SREBPs.
When SEB-1 cells were treated with 20 ng/ml IGF-1 or
1 mM insulin, we found that both the precursor and cleaved
SREBP-1 protein levels were increased, while 100 nM insulin
had no effect on SREBP-1 protein. The modest increase in
lipogenesis in cells treated with 100 nM insulin combined
with the lack of induction of SREBP-1 protein in this group
provides evidence for an SREBP-1-independent mechanism
by which sebaceous gland lipogenesis can be increased.
However, activation of the IGF-1 receptor, and ultimately,
SREBP-1 is required for maximal stimulation.
The two transcripts of the SREBP-1 protein are formed
from a single gene with alternate transcription start sites
which yields two mRNA species that have different first
exons, but are the identical from the second exon onward
(Shimomura et al., 1997). In this first exon, the 1a variant has
a much longer activation domain, making it a much more
potent activator of sterol response elements than the 1c
variant. As such, SREBP-1c has been reported to be regulated
more at the transcriptional level, particularly by insulin, while
SREBP-1a appears to be regulated at the protein processing
stage (Eberle et al., 2004). Here, we show that in SEB-1
sebocytes, both the SREBP-1a and SREBP-1c mRNA tran-
scripts are increased in response to IGF-1 treatment and two
doses of insulin. The increase in SREBP-1c mRNA was
expected as this response to insulin has been well character-
ized. However, the increase in SREBP-1a transcript was not
as robust as the increase in SREBP-1c. This is attributed to the
fact that the 1a promoter contains only two Sp1 elements
which are relatively weak activators of transcription (Zhang
et al., 2005). Sp1 elements have been shown to activate
transcription in response to insulin (Samson and Wong,
2002), which is most likely responsible for the increase in
response to IGF-1 as well. In agreement with our findings,
increases in SREBP-1a mRNA have been reported in 3T3-L1
adipocytes when differentiated by adipogenic hormones
(Shimomura et al., 1997). SEB-1 cells, like HepG2 cells, or
3T3-L1 adipocytes have more SREBP-1a compared to SREBP-
1c, which is reversed compared to the tissues from which
these cell lines were derived (Shimomura et al., 1997).
Whereas, numerous studies link the action of insulin to
SREBPs, there is a very limited body of work connecting the
IGF-1 and SREBP pathways, none of which has been
investigated in the sebaceous gland. IGF-1 increases low-
density lipoprotein receptor expression in HepG2 cells.
Significantly less activation of an low-density lipoprotein
receptor reporter construct is noted, however, in a HepG2-
derived cell line that exhibits decreased expression of SREBP-
1 (Streicher et al., 1996). Although artificial and indirect,
these data indicate that the effect of IGF-1 on low-density
lipoprotein receptor expression may be mediated by SREBP-1
which would support the relationship between IGF-1 and
SREBP-1 we report here. In addition, a functional IGF
receptor is necessary for insulin to induce SREBP protein
and its downstream effects in an immortalized brown fat cell
line (Mur et al., 2003). In this model IGF-1 can stimulate fatty
acid synthase RNA (Arribas et al., 2003). Fatty acid synthase
RNA may correlate directly with SREBP activity (Kim et al.,
1998), though there are exceptions (Palmer et al., 2002;
Louveau and Gondret, 2004). Taken together, these studies
support our finding that IGF-1 activates SREBP-1, which in
turn increases de novo lipid production. To our knowledge,
we are the first to directly show an increase in SREBP-1
protein in response to IGF-1.
Our data suggest that different molecular mechanisms
might underlie the increase in lipogenesis induced by low
doses of insulin (acting via the insulin receptor) compared to
IGF-1 and 1 mM insulin (acting via the IGF-1 receptor). Each of
these treatments increased mRNA for SREBP-1a and SREBP-
1c, yet 100 nM insulin failed to increase SREBP-1 protein. The
reasons for this discrepancy are not apparent but could in-
volve differences in transcript or protein stability. Additional
studies are needed to test these hypotheses.
Androgens are major regulators of sebaceous gland
function. Interestingly, the SREBP pathway has been impli-
cated in the actions of androgens in stimulating lipogenesis in
sebaceous glands. Rosignoli et al. (2003) showed that the
increased lipogenesis observed in the hamster ear model in
response to androgen treatment is mediated by the SREBP
pathway. In agreement with our findings with insulin and
IGF-1, both the SREBP-1a and 1c transcripts were increased
in response to this treatment.
Our work confirms that SREBP proteins are indeed
important mediators of sebaceous lipid metabolism. An
understanding of the mechanisms by which insulin and
IGF-1 increase SREBP-1 expression will move us one step
closer to understanding the underlying molecular mechan-
isms that govern skin lipid production. Finally, this work
demonstrates that SREBP proteins, considered to be, ‘‘Master
regulators of lipid homeostasis’’ (Eberle et al., 2004) are
important in the sebaceous gland and are regulated by IGF-1
and high-dose insulin. The SEB-1 sebocyte model could be a
useful tool for dissecting the differences between insulin and
IGF-1 signaling which may provide further insight into the
factors regulating human sebum production and the devel-
opment of acne.
MATERIALS AND METHODS
Cell culture
SEB-1 (passage 22–24) SV40 immortalized human sebocytes were
grown to confluence in all experiments unless stated otherwise, and
were cultured in standard medium consisting of DMEM (Invitrogen,
Carlsbad, CA), 5.5 mM glucose/Ham’s F-12 3:1 (Invitrogen), fetal
bovine serum 2.5% (HyClone, Logan, UT), adenine 1.8 104 M
(Sigma, St Louis, MO), hydrocortisone 0.4 mg/ml (Sigma), insulin
10 ng/ml (Sigma), epidermal growth factor 3 ng/ml (Austral Biologi-
cals, San Ramon, CA), and cholera toxin 1.2 1010 M (Sigma)
(Thiboutot et al., 2003).
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Cell treatments
To determine if adipogenic hormones induce differentiation of SEB-1
cells, cells were grown to 80% confluence in standard medium and
treated with a combination of methylisobutylxanthine (0.5 mM)
(Sigma), dexamethasone (0.3mM) (Sigma), and insulin (1.74mM) from
Sigma in medium containing DMEM 5.5 mM glucose, 10% fetal
bovine serum, and antibiotics for 72 hours (Student et al., 1980).
Additional plates were assayed using the appropriate drug vehicle
controls in the same medium.
For all treatments with insulin or IGF-1, confluent cells were
washed twice with phosphate-buffered saline and treated with the
appropriate hormone or vehicle in DMEM with no additives or
serum for 24 hours. Thus, the control media in experiments with
insulin or IGF-1 consisted of DMEM without additives plus the
appropriate vehicle. IGF-1 (Invitrogen) was diluted 1:1,000 in 0.1 M
acetic acid with 0.1% BSA. The final concentration was 20 ng/ml.
Insulin was also added 1:1,000 in 0.005 N HCl.
Lipogenesis assay
The incorporation of 14C-acetate into lipids was used as a measure of
lipogenesis. SEB-1 cells were cultured in standard medium until
confluent and treated in different experiments with a combination of
adipogenic hormones or each hormone individually as above for
72 hours. In experiments examining the effects of IGF-1 on
lipogenesis, cells were treated with IGF-1 or the vehicle (0.1%
BSA in 0.1 M acetic acid) in DMEM without additives or serum for
24 hours. In all experiments, cell counts were used to normalize the
data. The remaining cells were suspended in a DMEM solution
containing 1 mCi 14C-acetate (New England Nuclear, Boston, MA),
incubated for 2 hours at 371C with agitation, and extracted twice
with ethyl ether and non-radioactive carrier lipids. Samples were
dissolved in a small volume of ethyl acetate and spotted on 20 cm
silica gel thin layer chromatography plates (Macherey-Nagel, Easton,
PA) which were run until the solvent front reached 19.5 cm in
hexane, followed by 19.5 cm in benzene, and finally to 11 cm in
hexane:ethyl ether:glacial acetic acid (69.5:30:1.5). Lipids were
visualized and all lipid-containing zones were counted in a liquid
scintillation counter. Negative controls for each experiment con-
sisted of plates of untreated cells where radioactivity was added and
cells were incubated on ice for 2 hours; lipids were extracted and
analyzed in parallel. All experiments were repeated a minimum of
three times with each sample in triplicate within each experiment.
Data analysis is described in the individual figure legends.
Western blot
Cytoplasmic and nuclear lysates were obtained using the Ne-Per kit
(Pierce, Rockford, IL) following manufacturer’s instructions. A
protease inhibitor cocktail (Sigma) containing 4-(2-aminoethyl)
benzenesulfonyl fluoride, pepstatinA, E-64, bestatin, leupeptin, and
aprotinin was added. Both the mature and precursor forms of the
SREBP-1 proteins were found in the nuclear fraction in SEB-1 cells.
This appears to be unique to the SEB-1 cells, since the endoplasmic
reticulum is solubilized by the cytoplasmic detergents in the Ne-Per
kit. Western blot for the endoplasmic reticulum protein GRP-78
revealed that this marker was present in both the nuclear and cyto-
plasmic fraction (data not shown). Thus, all Western blots shown using
SEB-1 extracts are the nuclear fractions. Total protein for each sample
was determined using the Bio-Rad DC protein assay (Bio-Rad,
Hercules, CA). Twenty-five micrograms of protein, was run on a
4–12% Bis-Tris NuPage polyacrylamide gel (Invitrogen). Protein was
then transferred to a polyvinylidene fluoride membrane and probed
using standard methods. The SREBP-1 (K-10) antibody was obtained
from Santa Cruz and used at a dilution of 1:2,000. Preliminary
experiments showed that this antibody reacts non-specifically with a
protein at 80 kDa. This was confirmed to be nonspecific using the
SREBP-1 (K-10) blocking peptide (Santa Cruz) (data not shown). The
actin antibody and goat anti-rabbit secondary antibody (7074) were
obtained from Cell Signaling Technologies (Beverly, MA) and were
used at 1:5,000 and 1:2,000 dilutions, respectively. Blots were
developed with SuperSignal West Pico Chemiluminescent Substrate
(Pierce) and exposed to film. Films of blots were analyzed and
quantified by densitometry with QuantityOne Software (Bio-Rad)
after background subtraction. Western blots were repeated a
minimum of three times. Data were analyzed using Student’s t-test
and results were considered significant if Po0.05.
QPCR
QPCR was performed to compare the ratios of SREBP-1a and 1c
mRNA transcripts in SEB-1 sebocytes and human sebaceous glands.
For QPCR with SEB-1 cells, cells were grown in standard medium for
6 days. On day 7, cells were washed twice with phosphate-buffered
saline and treated with insulin, IGF-1 or the appropriate vehicle in
serum-free DMEM for 14 hours. RNA was isolated and complimentary
DNA was generated from 4.2mg RNA/reaction primed with oligo-dT
using the SuperScript First-Strand Synthesis System for RT-PCR
(Invitrogen). QPCR was performed using the Brilliant SYBR Green
QPCR Core Reagent Kit in an Mx4000 Multiplex Quantitative PCR
System (Stratagene, La Jolla, CA). TATA-binding protein, a house-
keeping gene, was used as a reference gene. The following primer
sequences were used: TATA-binding protein upstream (GenBank
number NM_003194) 50c acg gca ctg att ttc agt tct, TATA-binding
protein downstream 50ttc ttg ctg cca gtc tgg act, SREBP-1a upstream
(GenBank number NM_004176) 50gct gct gac cga cat cga a, SREBP-
1c upstream (GenBank number NM_001005291) 50gga gcc atg gat tgc
act tt, and SREBP-1a,c downstream 50tca aat agg cca ggg aag tca. Data
were analyzed using the REST-XL& program (Pfaffl et al., 2002). A
P-value o0.05 was considered significant.
Facial skin samples were obtained under a protocol approved by
the Institutional Review Board of the Pennsylvania State University
College of Medicine; informed consent was obtained from the
subjects and the study was conducted according to the principles
outlined in the Declaration of Helsinki Principles. Sebaceous glands
were microdissected as previously described (Thiboutot et al., 1995).
Owing to a limited number of sebaceous gland samples, threshold
values (Ct) were transformed using the formula (2
Ct ) 107 as
described (Spangler et al., 2003) and normalized to TATA-binding
protein. The relative difference between SREBP-1c and 1a is a ratio
of normalized 1c to 1a.
The ratio of insulin receptor A-type (exon 11) to insulin receptor
B-type (exon-11þ ) was determined by relative QPCR as described
previously (Trivedi et al., 2006). SEB-1 sebocytes were grown to 50%
confluence and the RNA was extracted. Both primer/probe sets were
purchased from ABI. For the insulin receptor A-type (GenBank
number AB208861) the primer/probe set Hs00965956_m1 was
used. For the B-type (GenBank number NM_000208) the primer/
probe set Hs00169631_m1 was used.
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